Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Sorrento Therapeutics Inc

+ Add to Watchlist

8STN:GR

12.482 EUR 0.599 5.04%

As of 09:31:21 ET on 03/06/2015.

Snapshot for Sorrento Therapeutics Inc (8STN)

Open: 12.286 Day's Range: 12.286 - 12.482 Volume: 0
Previous Close: 11.883 52wk Range: 2.477 - 12.482 1-Yr Rtn: +30.02%

Stock Chart for 8STN

No chart data available.
  • 8STN:GR 12.286
  • 1D
  • 1M
  • 1Y
11.883
Interactive 8STN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 8STN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.2770
Est. PEG Ratio -
Market Cap (M EUR) 452.15
Shares Outstanding (M) 36.22
30 Day Average Volume 18
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/01/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 8STN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 8STN

Sorrento Therapeutics, Inc. is a biopharmaceutical company. The Company researches human therapeutic antibodies for the treatment of cancer, inflammation, metabolic disease and infectious disease.

Henry JiPresident/CEOZhenwei MiaoChief Technology Officer
George UyChief Commercial OfficerDouglas LangstonVP:Finance
More Company Profile & Key Executives for 8STN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil